BioArctic AB (publ)
The answer first
Does BioArctic beat the market?
No, BioArctic has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 19% of Nordic stocks
- Quality55
- Value5
- Trend44
No. 134 of 195 in healthcare
Expectations in the price
High expectations
For the share to return about 9% a year from today's price, the cash BioArctic keeps must grow about 29% a year for 10 years.
Max for seven days
Follow BioArctic with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about BioArctic
Your first answer is free, no account needed.
Do you own BioArctic, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with BioArctic and a few more. Free, no card.
Super Stock+44.6%In short
- BioArctic has risen 9.3% over the past year, including dividends.
- Overall, BioArctic ranks better than 19% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 63.0%. The price is 19.0% below its peak now.
Who owns BioArctic? See the major shareholders and their stakes
What do analysts think of BioArctic?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 19% of Nordic stocks.
No. 134 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 117 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.07
- Asset turnoverSales divided by everything the company owns0.36
- Return on equityProfit divided by equity+5.2%
- Cash conversionOperating cash flow divided by profit2.31
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 164 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity12.8
- P/SPrice divided by sales25.7
- P/EPrice divided by earnings244.3
- P/CFPrice divided by operating cash flow105.7
The ranking is built on P/E, P/B and P/S.
Medium The share price has moved about like most stocks over the last year.
No. 79 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−9.3%
- 6 months−8.3%
- 9 months−12.2%
- 12 months+9.3%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own BioArctic
42 funds we follow own BioArctic. The share is how much of the fund the stock makes up.
- Norway1
- Sweden41
- 1 ETF
- PLUS Hälsovård Sverige IndexSweden · PLUS5.0%
- Lannebo Sverige PlusSweden · Lannebo4.6%
- Lannebo SverigeSweden · Lannebo4.6%
- Indecap Guide Q30 ASweden · Indecap3.7%
- Simplicity Småbolag Sverige ASweden · Simplicity2.3%
- Kvartil Nordiska Småbolag+ Faktor ASweden · Kvartil1.4%
- Öhman Sweden Micro Cap ASweden · Öhman1.2%
- FE Småbolag Sverige ASweden · FE Småbolag1.2%
Show all 42
- Öhman Småbolagsfond ASweden · Öhman1.2%
- PLUS Småbolag Sverige IndexSweden · PLUS0.7%
- Simplicity SverigeSweden · Simplicity0.7%
- HealthInvest Small & MicroCap Fund CSweden · HealthInvest0.7%
- HealthInvest Small & Mid Cap Healthcare ESweden · HealthInvest0.7%
- Nordea AlfaSweden · Nordea0.7%
- Nordea OlympiafondSweden · Nordea0.6%
- Skandia Småbolag Sverige Exponering ASweden · Skandia0.6%
- Handelsbanken Hälsovård Tema (A1 SEK)Sweden · Handelsbanken0.5%
- Xact Svenska Småbolag (UCITS ETF)Sweden · XACT · ETF0.5%
- Handelsbanken Nordiska Småbol (A1 NOK)Sweden · Handelsbanken0.4%
- Indecap Guide 2 BSweden · Indecap0.4%
- Simplicity NordenSweden · Simplicity0.4%
- Avanza Sweden All Cap ASweden · Avanza0.3%
- Handelsbanken Norden Ind Crit (A1 NOK)Sweden · Handelsbanken0.2%
- SPP Aktiefond Sverige ASweden · SPP0.2%
- Skandia Sverige ExponeringSweden · Skandia0.2%
- Öhman Etisk Index Sverige ASweden · Öhman0.2%
- Nordea Inst Aktie SverigeSweden · Nordea0.2%
- PLUS Allabolag Sverige IndexSweden · PLUS0.2%
- Nordnet Indexfond SverigeSweden · Nordnet0.2%
- Swedbank Robur Access Edge Sweden ASweden · Swedbank Robur0.1%
- Swedbank Robur Access Sverige ASweden · Swedbank Robur0.1%
- Öhman Sverige Marknad Hållbar ASweden · Öhman0.1%
- KLP AksjeNorden IndeksNorway · KLP0.1%
- Skandia Världen SverigeSweden · Skandia0.1%
- Lannebo Hälsa och Ny Teknik ASweden · Lannebo0.1%
- GodFond Sverige & VärldenSweden · GodFond0.0%
- Nordea Donationsmedelsfond utdSweden · Nordea0.0%
- Handelsbanken Gl Småbolag I Crit A9 EURSweden · Handelsbanken0.0%
- Handelsbanken Gl Småbolag Ind Cri A1 NOKSweden · Handelsbanken0.0%
- Länsförsäkringar Sparmål 2025Sweden · Länsförsäkringar0.0%
- Länsförsäkringar Sparmål 2030Sweden · Länsförsäkringar0.0%
- Skandia SMART FörsiktigSweden · Skandia0.0%
From the funds' latest known holdings.
About BioArctic
BioArctic AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 150 employees.
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of biological drugs, such as antibodies that address high unmet medical needs. The company's therapeutic areas encompass neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and ALS. In addition, it offers lecanemab for intravenous treatment.


See the full analysis of BioArctic.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card